Awareness of sleep apnea and its relatively common and effective treatment has grown over the past three decades.

There are many consequences of untreated OSA, and all of these are more likely with more-severe obstruction. Because people ...

Popular Eli Lilly weight-loss drug Zepbound can be covered by Medicare plans to treat sleep apnea after it received Food and ...

You don’t realize that you could be sleeping for eight hours but when you get tested you actually only slept for one or two.” ...

Leerink Partners analyst Mike Kratky has maintained their neutral stance on INSP stock, giving a Hold rating on January 13.Stay Ahead of the ...

Obstructive Sleep Apnea affects 1 in 15 Americans, likely more, and treatment has often involved inconvenient treatments like CPAP machines. A new device called Inspire offers new alternatives for ...

Nyxoah's Genio implant is poised to revolutionize Obstructive Sleep Apnea treatment ... are other companies offering treatment for OSA, such as ResMed (RMD) and Inspire Medical Systems (INSP).

The Centers for Medicare & Medicaid Services confirmed to CNBC that Medicare drug plans can now cover Eli Lilly’s (LLY) obesity drug ...

and PDMA-approved neurostimulation technology of its kind that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. For additional information about Inspire ...